P-94 Pembrolizumab plus lenvatinib vs chemotherapy and lenvatinib monotherapy for recurrent/metastatic head and neck squamous cell carcinoma that progressed on platinum therapy and immunotherapy: LEAP-009

Authors :: Barbara Burtness
Ezra E.W. Cohen
Natalyn Hawk
Behzad Bidadi
Makoto Tahara
Jean-Pascal Machiels
Jan B. Vermorken
Ramona F. Swaby
Joy Yang Ge
Lisa Licitra
Lillian L. Siu
Danny Rischin
Le Quynh
Kevin J. Harrington
Source :: Oral Oncology. 118:10-11
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Chemotherapy
business.industry
medicine.medical_treatment
Pembrolizumab
Immunotherapy
medicine.disease
Head and neck squamous-cell carcinoma
chemistry.chemical_compound
chemistry
Internal medicine
medicine
Oral Surgery
business
Lenvatinib

Full Text Access

Tools